1. Home
  2. HALO vs CAE Comparison

HALO vs CAE Comparison

Compare HALO & CAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • CAE
  • Stock Information
  • Founded
  • HALO 1998
  • CAE 1947
  • Country
  • HALO United States
  • CAE Canada
  • Employees
  • HALO N/A
  • CAE N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • CAE
  • Sector
  • HALO Health Care
  • CAE
  • Exchange
  • HALO Nasdaq
  • CAE Nasdaq
  • Market Cap
  • HALO 7.4B
  • CAE 8.1B
  • IPO Year
  • HALO N/A
  • CAE N/A
  • Fundamental
  • Price
  • HALO $54.54
  • CAE $25.05
  • Analyst Decision
  • HALO Buy
  • CAE Buy
  • Analyst Count
  • HALO 9
  • CAE 3
  • Target Price
  • HALO $63.56
  • CAE $32.33
  • AVG Volume (30 Days)
  • HALO 3.3M
  • CAE 563.0K
  • Earning Date
  • HALO 05-06-2025
  • CAE 05-13-2025
  • Dividend Yield
  • HALO N/A
  • CAE N/A
  • EPS Growth
  • HALO 55.40
  • CAE N/A
  • EPS
  • HALO 3.76
  • CAE 0.88
  • Revenue
  • HALO $1,084,306,000.00
  • CAE $3,275,402,649.00
  • Revenue This Year
  • HALO $25.77
  • CAE $8.43
  • Revenue Next Year
  • HALO $18.01
  • CAE $5.82
  • P/E Ratio
  • HALO $14.51
  • CAE $28.34
  • Revenue Growth
  • HALO 25.64
  • CAE 9.93
  • 52 Week Low
  • HALO $42.01
  • CAE $15.95
  • 52 Week High
  • HALO $70.51
  • CAE $27.62
  • Technical
  • Relative Strength Index (RSI)
  • HALO 44.48
  • CAE 50.52
  • Support Level
  • HALO $52.43
  • CAE $24.57
  • Resistance Level
  • HALO $54.26
  • CAE $26.10
  • Average True Range (ATR)
  • HALO 3.42
  • CAE 0.65
  • MACD
  • HALO -0.49
  • CAE -0.13
  • Stochastic Oscillator
  • HALO 30.60
  • CAE 42.55

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About CAE CAE Inc.

CAE Inc provides training and aviation services, integrated enterprise solutions, in-service support, and crew-sourcing services. The company operations are managed through two segments: Civil Aviation which offers comprehensive training solutions for flight, cabin, maintenance, and ground personnel in commercial, business, and helicopter aviation, a complete range of flight simulation training devices, ab initio pilot training, and crew sourcing services, as well as aircraft flight operations solutions; and Defense and Security which is a global training and simulation provider delivering scalable, platform-independent solutions that enable and enhance force readiness and security. It generates the majority of its revenue from the Civil Aviation segment.

Share on Social Networks: